Decentralized Trial Technology Resources
-
eCOA/ePRO: Why Patients Deserve Even More Progress
5/11/2022
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
Safety Monitoring: What Does ePRO Have To Do With It?
1/10/2022
In the available blog post, learn about the importance of safety monitoring in clinical trials.
-
Defining 'Evidence Generation' Within Modern Clinical Trials
1/26/2024
Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.
-
The Win-Win Wth Virtual Visits – Better Experiences, Better Data
2/29/2024
Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.
-
Preparing Studies With eConsent For IRB Approval
6/7/2023
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
How Actigraphy Is Clearing Operational Barriers To Decentralized Trials
3/8/2022
In this white paper, explore why sponsors are turning to proven systems for collecting real-world data to support their DCTs.
-
A Better Approach To eConsent: Flexibility With Enabled Technology
1/11/2023
Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.
-
One Key To Choosing The Best eClinical Technology Vendor
2/29/2024
Explore why the integration of etechnologies is critical in the modernization and optimization of clinical trials, and how the right partner will ensure studies are more efficient, reliable, and inclusive.
-
Come To The Dark (Mode) Side
3/7/2022
Many of the decisions made by a product team start as suggestions from a user community of clinical professionals. While planning the development of a recently launched CTMS, a focus group was led where clinical professionals weighed in on potential improvements for a new system.
-
Trends Shaping The Pharmaceutical Industry's Future
4/10/2024
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.